NCT00569283View on ClinicalTrials.gov

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Cancer
Interventions
BIOLOGICAL

therapeutic allogeneic lymphocytes

Trial Locations (2)

305-806

Korea Research Institute of Bioscience and Biotechnology, Dajeon

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER